
<DOC>
<DOCNO>
WSJ900919-0134
</DOCNO>
<DOCID>
900919-0134.
</DOCID>
<HL>
   Syntex Unit Deworming Agent
</HL>
<DATE>
09/19/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   SYN
</CO>
<IN>
DRUG MANUFACTURERS (DRG)
</IN>
<GV>
FOOD AND DRUG ADMINISTRATION (FDA)
</GV>
<LP>
   PALO ALTO, Calif. -- Syntex Corp. said that its Syntex
Animal Health Inc. unit received approval from the U.S. Food
and Drug Administration to market Synanthic Bovine Dewormer
Suspensions, or oxfendazole, to treat common internal
parasites in cattle.
   The deworming agent should be available from distributors
and veterinarians in about three weeks, the company said.
</LP>
<TEXT>
   The drug has been used for 10 years in many countries and
was first introduced in Ireland in 1978.
</TEXT>
</DOC>